SCHEMBL21716237

SCHEMBL21716237

c1ccc2cc(-c3nc4ccccc4nc3-c3ccc(-n4c5ccc(-n6c7ccccc7c7c8ccccc8ccc76)cc5c5cc6ccccc6cc54)cc3)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 4/20 0.36
MAPK9 P45984 2/20 0.36
MAPK8 P45983 1/20 0.36
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
HTR2B P41595 1/20 0.32
HTR5A P47898 1/20 0.32
HPGD P15428 2/20 0.32
POLB P06746 2/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HSP90AA1 P07900 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
HTT P42858 1/20 0.32
GRK6 P43250 1/20 0.32
PTGES O14684 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717027 0.97 HPGD (0.34) MAPK10MAPK9MAPK8ADORA2AADORA1
SCHEMBL21717026 0.95 LMNA (0.34) MAPK10MAPK9MAPK8ADORA2AADORA1
SCHEMBL21716240 0.95 L3MBTL1 (0.36) HPGDPOLBLMNAKDM4EGAA
SCHEMBL21716254 0.94 ADORA2A (0.35) MAPK10MAPK9MAPK8ADORA2AADORA1
SCHEMBL21716849 0.94 PTGES (0.32) MAPK10MAPK9MAPK8POLBLMNA
SCHEMBL21716897 0.94 L3MBTL1 (0.35) LMNAKDM4EHSP90AA1GAAMAPT
SCHEMBL21716214 0.92 MAPK10 (0.36) MAPK10MAPK9MAPK8ADORA2AADORA1
SCHEMBL21716714 0.92 MAPK10 (0.36) MAPK10MAPK9MAPK8ADORA2AADORA1
SCHEMBL21717535 0.92 PTGES (0.34) MAPK10MAPK9MAPK8HPGDPOLB
SCHEMBL21716424 0.92 TUBB4A (0.32) MAPK10MAPK9MAPK8HTR2BHTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 MAPK10 1751/4885MAPK9 1041/4885MAPK8 1985/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 MAPK10 1751/4885MAPK9 1041/4885MAPK8 1985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.